117 related articles for article (PubMed ID: 2380174)
1. Purification of the 5-hydroxytryptamine 5-HT3 receptor from NCB20 cells.
McKernan RM; Gillard NP; Quirk K; Kneen CO; Stevenson GI; Swain CJ; Ragan CI
J Biol Chem; 1990 Aug; 265(23):13572-7. PubMed ID: 2380174
[TBL] [Abstract][Full Text] [Related]
2. Molecular size of the 5-HT3 receptor solubilized from NCB 20 cells.
McKernan RM; Biggs CS; Gillard N; Quirk K; Ragan CI
Biochem J; 1990 Aug; 269(3):623-8. PubMed ID: 2390056
[TBL] [Abstract][Full Text] [Related]
3. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
Fletcher S; Barnes NM
Br J Pharmacol; 1997 Oct; 122(4):655-62. PubMed ID: 9375961
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a mouse serotonin 5-HT3 receptor purified from mammalian cells.
Hovius R; Tairi AP; Blasey H; Bernard A; Lundström K; Vogel H
J Neurochem; 1998 Feb; 70(2):824-34. PubMed ID: 9453579
[TBL] [Abstract][Full Text] [Related]
7. Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930.
Hoyer D; Neijt HC; Karpf A
J Recept Res; 1989; 9(1):65-79. PubMed ID: 2915346
[TBL] [Abstract][Full Text] [Related]
8. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930.
Neijt HC; Karpf A; Schoeffter P; Engel G; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):493-9. PubMed ID: 3412489
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of a 5-HT3 binding site from rabbit small bowel muscularis membranes.
Gordon JC; Sarbin NS; Barefoot DS; Pinkus LM
Eur J Pharmacol; 1990 Jun; 188(6):313-9. PubMed ID: 2373145
[TBL] [Abstract][Full Text] [Related]
11. Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes.
McKernan RM; Quirk K; Jackson RG; Ragan CI
J Neurochem; 1990 Mar; 54(3):924-30. PubMed ID: 2303819
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of the rat pancreatic cholecystokinin receptor.
Duong LT; Hadac EM; Miller LJ; Vlasuk GP
J Biol Chem; 1989 Oct; 264(30):17990-6. PubMed ID: 2808360
[TBL] [Abstract][Full Text] [Related]
13. Solubilization and characterization of high-affinity [3H]serotonin binding sites from bovine cortical membranes.
VandenBerg SR; Allgren RL; Todd RD; Ciaranello RD
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3508-12. PubMed ID: 6574495
[TBL] [Abstract][Full Text] [Related]
14. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
15. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
16. A kainic acid receptor from frog brain purified using domoic acid affinity chromatography.
Hampson DR; Wenthold RJ
J Biol Chem; 1988 Feb; 263(5):2500-5. PubMed ID: 2828372
[TBL] [Abstract][Full Text] [Related]
17. Purification to homogeneity of an active opioid receptor from rat brain by affinity chromatography.
Loukas S; Mercouris M; Panetsos F; Zioudrou C
Proc Natl Acad Sci U S A; 1994 May; 91(10):4574-8. PubMed ID: 8183950
[TBL] [Abstract][Full Text] [Related]
18. Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.
Glaum SR; Anderson EG
Eur J Pharmacol; 1988 Nov; 156(2):287-90. PubMed ID: 3240771
[TBL] [Abstract][Full Text] [Related]
19. Molecular properties of 5-hydroxytryptamine3 receptor-type binding sites purified from NG108-15 cells.
Boess FG; Lummis SC; Martin IL
J Neurochem; 1992 Nov; 59(5):1692-701. PubMed ID: 1402914
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
